The decision follows the company’s claims that its drops could reduce the dependency on reading glasses for individuals ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

Taking serious note of Mumbai-based Entod Pharmaceuticals’ claims that it can help reduce dependency on reading glasses for ...

The national drugs regulator has suspended its approval for Mumbai-based Entod Pharmaceuticals to make and sell its “PresVu” ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which ...

DCGI suspends permission of Entod Pharma's ophthalmic solution PresVu: Our Bureau, New Delhi Wednesday, September 11, 2024, 17:20 Hrs [IST] The Central drug regulator has suspende ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

The Drugs Controller General of India (DCGI) has suspended Entod Pharmaceuticals' approval to manufacture and market eye drops designed to reduce dependency on reading glasses for presbyopia. The ...

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...